Han Ma joined BeiGene in 2021 and serves as the Chief Safety Officer and Senior Vice President of Global Patient Safety. Dr. Ma brings nearly two decades of experience in the biopharmaceutical industry, spanning pre- and post-market clinical safety and risk management with a significant oncology focus. Most recently, she served as Global Patient Safety’s Vice President for Safety Science and Epidemiology.

Dr. Ma’s broad experience across the product lifecycle bridges clinical development with safety in support of making innovative medicines available to patients globally. Prior to joining BeiGene, she spent 20 years at Roche/Genentech in leadership roles with increasing responsibility within clinical development, discovery and translational research, and patient safety. Notably, while at Roche, she served as Global Group Medical Director responsible for building and leading a safety sciences team in Shanghai supporting the whole Roche product portfolio in China and prior to that served as the lead for their global molecular virology and pharmacology group within the infectious diseases therapeutic area. Prior to joining the industry, she was a clinical oncologist for 6 years working directly with patients.

Dr. Ma earned a medical degree from Shanghai Medical College of Fudan University and a Ph.D. in molecular pathobiology from the University of Southern California.